Review of medicines approved by the Food and Drug Administration from 2012 to 2024

The aim. To describe the key characteristics of medical products approved by the Food and Drug Administration (FDA) and released by pharmaceutical companies from 2012 to 2024.Materials and methods. The analysis is based on data from FDA publications related to the approval of medical products from 2...

Popoln opis

Bibliografske podrobnosti

Principais autores:	D. V. Kurkin, N. A. Osadchenko, D. A. Bakulin, E. I. Morkovin, S. A. Voskresenskiy, D. V. Maltsev, M. O. Maltseva, Yu. V. Gorbunova, O. V. Marincheva, V. I. Zvereva, Yu. A. Kolosov, E. V. Pavlova, I. S. Krysanov, D. A. Galkina, A. V. Zaborovskiy, A. V. Strygin, K. N. Koryanova, O. A. Akhverdova, L. Kh. Akaeva, L. S. Idrisova, Zh. I. Glushanyan, I. E. Makarenko, R. V. Drai, A. S. Shuvaeva, O. V. Shatalova, V. I. Petrov
Format:	Artigo
Jezik:	Russo
Izdano:	Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2025-11-01
Serija:	Фармация и фармакология (Пятигорск)
Teme:	fda атх таргетная терапия тенденции лекарственного дизайна одобренные лекарственные препараты новые лекарственные препараты
Online dostop:	https://www.pharmpharm.ru/jour/article/view/1761
Oznake:	Označite Brez oznak, prvi označite!